SUBSCRIBE
SUBSCRIBE

Walking Fish Therapeutics, Inc.

NEWS
Walking Fish Therapeutics closed May, 2024.
Drug Development
Money on the Move: February 16–22
More biotech companies turn to private investors as the market churns volatile for life sciences. Here’s who’s scooping up the cash this week.
February 23, 2022
 · 
3 min read
 · 
Kate Goodwin
Business
Top Life Sciences Startups to Watch in 2022
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
January 4, 2022
 · 
19 min read
 · 
Heather McKenzie
Business
Money on the Move: September 8 – 14
Ramping up after the Labor Day holiday, funds are flowing fast and free into these life science companies.
September 15, 2021
 · 
5 min read
 · 
Kate Goodwin
IN THE PRESS
Business
Walking Fish Therapeutics Expands Leadership Team
June 1, 2023
 · 
3 min read
Business
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
May 4, 2023
 · 
3 min read
Business
Walking Fish Therapeutics Expands Leadership Team and Debuts New Headquarters as it Advances Its B Cell Therapeutics Towards Clinical Trials
September 6, 2022
 · 
1 min read
Biotech Bay
Walking Fish Therapeutics Closes $73 Million Series A Financing
February 16, 2022
 · 
2 min read
Biotech Bay
Walking Fish Therapeutics Launches with $50 Million in Series A Financing to Accelerate Development of B Cell Therapies for Multiple Diseases
September 13, 2021
 · 
3 min read
AWARDS
  • NextGen Class of 2022